Oncology Central

Promising interim results from 680-subject colorectal cancer clinical trial

Researchers have reported high detection rates of Stage I cancer and pre-cancerous adenomas in colorectal cancer screening trial for Nu.Q™ blood test involving 680 subjects.

The interim results demonstrated that a panel of three ELISA assays, when considered with the subjects’ ages and smoking histories, produced an

To view restricted content, please:



News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.